Mallette L E, Bradley W A
J Lab Clin Med. 1981 Dec;98(6):886-95.
Radioiodinated bPTH has been widely used as the labeled ligand in the radioimmunoassay of PTH. We now report the properties of a carboxyterminal fragment of bPTH that has several favorable characteristics when used as radioligand. This peptide, the chief component of a commercial preparation of bPTH, was isolated by gel filtration, where it migrated more slowly than did authentic bPTH-(1-84). It yielded lower nonspecific binding values and more sensitive hPTH assays than were seen with the intact hormone. By immunological criteria this peptide lacked the aminoterminal region of PTH, since hPTH-(1-34) did not inhibit its binding to any of 11 different antisera with known ability to recognize the aminoterminal region of PTH. The peptide did not contain most or all of the carboxyterminal region, however, since its binding to anti-PTH sera was inhibited by hPTH-(44-68) or hPTH-(53-84). Sequential Edman degradation of the iodinated peptide released iodotyrosine at the third cycle, suggesting the structure, bPTH-(41-84). The lower nonspecific binding and enhanced assay sensitivity provided by this peptide suggest that the use of other natural or synthetic fragments of PTH as radioligands might enhance the performance of PTH assays.
放射性碘化牛甲状旁腺激素(bPTH)已被广泛用作甲状旁腺激素(PTH)放射免疫测定中的标记配体。我们现在报告一种bPTH羧基末端片段的特性,该片段用作放射性配体时具有几个有利特征。这种肽是bPTH商业制剂的主要成分,通过凝胶过滤分离得到,在凝胶过滤中它的迁移速度比天然bPTH-(1-84)慢。与完整激素相比,它产生的非特异性结合值更低,人PTH(hPTH)测定更灵敏。根据免疫学标准,这种肽缺乏PTH的氨基末端区域,因为hPTH-(1-34)不能抑制其与11种已知能够识别PTH氨基末端区域的不同抗血清的结合。然而,该肽并不包含大部分或全部羧基末端区域,因为其与抗PTH血清的结合可被hPTH-(44-68)或hPTH-(53-84)抑制。对碘化肽进行连续的埃德曼降解,在第三个循环释放出碘酪氨酸,提示其结构为bPTH-(41-84)。该肽提供的较低非特异性结合和更高的测定灵敏度表明,使用PTH的其他天然或合成片段作为放射性配体可能会提高PTH测定的性能。